Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I like the diversity of topics that MedCity News covers – ranging from devices to policy to start-up companies. Always something interesting to find.”

Robert J. Szczerba, Ph.D., CEO, X Tech Ventures


Sign up for our daily newsletter


How Life Technologies will sequence the human genome for $1,000 (video)

January 13, 2012 8:00 am by | 0 Comments

The biggest new healthcare product unveiled at CES this week was undoubtedly Life Technologies Corp.’s (NASDAQ:LIFE) new Ion Proton Sequencer, a bench-top machine that the company says will be able to sequence the entire human genome for $1,000 by the end of the year. (A side note: Illumina Inc. announced the release of a similar product at the JP Morgan Healthcare conference.)

For many years, the idea has been that the $1,000 genome would accelerate disease diagnosis and improve drug development, and allow for more personalized treatment.

Life Technologies’ Ion Proton Sequencer, which costs $149,000, is the machine that enables the sequencing. But the real innovation is in the chip inserted into the machine, Graham Scott from Life Technologies’ Ion Torrent unit says.

The company will first sell $1,000 chips that enable only exomes to be decoded by the machine, with the second-generation chip for sequencing the whole genome becoming available six months later.

Advertisement

Customers that have already committed to purchasing the device include Baylor College of Medicine, Yale School of Medicine and Broad Institute. Upon the announcement, Life Technologies’ shares jumped 8.3 percent, their biggest single-day gain in three years.

In this video from CES, Scott describes how the technology that PC Magazine’s Dan Costa named “the coolest thing at CES” works.

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Deanna Pogorelc

By Deanna Pogorelc MedCity News

Deanna Pogorelc is a Cleveland-based reporter who writes obsessively about life science startups across the country, looking to technology transfer offices, startup incubators and investment funds to see what’s next in healthcare. She has a bachelor’s degree in journalism from Ball State University and previously covered business and education for a northeast Indiana newspaper.
More posts by Author

0 comments